APO Research
Talk to an analyst

APO RESEARCH · REPORT

Zika Virus

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.

Selected research

Industry Growth & Trends

Global Zika Virus Industry Growth and Trends Forecast to 2032

1 January 202691 pages

Choose your research edition.

Industry ResearchZika Virus Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Zika Virus Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Zika Virus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zika Virus Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Zika Virus Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.

Global Zika Virus key players include Chembio, Quest Diagnostics, ARUP Laboratories, Luminex Corporation, Simens, etc. Global top five manufacturers hold a share about 55%. North Amercia is the largest market, with a share about 45%, followed by Europe, with a share about 30 percent. In terms of product, Molecular Test is the largest segment, with a share about 90%. And in terms of application, the largest application is Diagnostic Centers, followed by Hospitals, Pathology Labs.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Zika Virus market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Zika Virus market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Zika Virus market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Zika Virus.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Zika Virus market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Zika Virus Market by Company

Bharat Biotech

Inovio Pharmaceuticals and GeneOne Life Sciences

Intrexon

Cerus

Sanofi

NewLink Genetics

Immunovaccine

GlaxoSmithKline

Zika Virus Segment by Type

Molecular Test

Serologic Test

Zika Virus Segment by Application

Diagnostic Centers

Hospitals

Pathology Labs

Zika Virus Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zika Virus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zika Virus and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zika Virus.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Zika Virus manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Zika Virus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Molecular Test Table 2. Major Company of Serologic Test Table 3. Global Zika Virus Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Zika Virus Sales by Type (2021-2026) & (K Units) Table 5. Global Zika Virus Sales Market Share in Volume by Type (2021-2026) Table 6. Global Zika Virus Sales by Type (2021-2026) & (US$ Million) Table 7. Global Zika Virus Sales Market Share in Value by Type (2021-2026) Table 8. Global Zika Virus Price by Type (2021-2026) & (USD/Unit) Table 9. Global Zika Virus Sales by Type (2027-2032) & (K Units) Table 10. Global Zika Virus Sales Market Share in Volume by Type (2027-2032) Table 11. Global Zika Virus Sales by Type (2027-2032) & (US$ Million) Table 12. Global Zika Virus Sales Market Share in Value by Type (2027-2032) Table 13. Global Zika Virus Price by Type (2027-2032) & (USD/Unit) Table 14. North America Zika Virus Sales by Type (2021-2026) & (K Units) Table 15. North America Zika Virus Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Zika Virus Sales by Type (2021-2026) & (K Units) Table 17. Europe Zika Virus Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Zika Virus Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Zika Virus Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Zika Virus Sales by Type (2021-2026) & (K Units) Table 21. Latin America Zika Virus Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Zika Virus Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Zika Virus Sales by Type (2021-2026) & (US$ Million) Table 24. Zika Virus Industry Trends Table 25. Zika Virus Industry Drivers Table 26. Zika Virus Industry Opportunities and Challenges Table 27. Zika Virus Industry Restraints Table 28. Global Zika Virus Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Zika Virus Revenue Market Share by Company (2021-2026) Table 30. Global Zika Virus Sales by Company (2021-2026) & (K Units) Table 31. Global Zika Virus Sales Share by Company (2021-2026) Table 32. Global Zika Virus Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Zika Virus Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Zika Virus Major Company Production Sites and Headquarters Table 35. Global Zika Virus Company, Product Type & Application Table 36. Global Zika Virus Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Zika Virus by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Zika Virus Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Zika Virus Sales by Region (2021-2026) & (K Units) Table 41. Global Zika Virus Sales Market Share in Volume by Region (2021-2026) Table 42. Global Zika Virus Sales by Region (2021-2026) & (US$ Million) Table 43. Global Zika Virus Sales Market Share in Value by Region (2021-2026) Table 44. Global Zika Virus Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Zika Virus Sales by Region (2027-2032) & (K Units) Table 46. Global Zika Virus Sales Market Share in Volume by Region (2027-2032) Table 47. Global Zika Virus Sales by Region (2027-2032) & (US$ Million) Table 48. Global Zika Virus Sales Market Share in Value by Region (2027-2032) Table 49. Global Zika Virus Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Zika Virus Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Zika Virus Sales by Application (2021-2026) & (K Units) Table 52. Global Zika Virus Sales Market Share in Volume by Application (2021-2026) Table 53. Global Zika Virus Sales by Application (2021-2026) & (US$ Million) Table 54. Global Zika Virus Sales Market Share in Value by Application (2021-2026) Table 55. Global Zika Virus Price by Application (2021-2026) & (USD/Unit) Table 56. Global Zika Virus Sales by Application (2027-2032) & (K Units) Table 57. Global Zika Virus Sales Market Share in Volume by Application (2027-2032) Table 58. Global Zika Virus Sales by Application (2027-2032) & (US$ Million) Table 59. Global Zika Virus Sales Market Share in Value by Application (2027-2032) Table 60. Global Zika Virus Price by Application (2027-2032) & (USD/Unit) Table 61. North America Zika Virus Sales by Application (2021-2026) & (K Units) Table 62. North America Zika Virus Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Zika Virus Sales by Application (2021-2026) & (K Units) Table 64. Europe Zika Virus Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Zika Virus Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Zika Virus Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Zika Virus Sales by Application (2021-2026) & (K Units) Table 68. Latin America Zika Virus Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Zika Virus Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Zika Virus Sales by Application (2021-2026) & (US$ Million) Table 71. Bharat Biotech Company Information Table 72. Bharat Biotech Business Overview Table 73. Bharat Biotech Zika Virus Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Bharat Biotech Zika Virus Product Portfolio Table 75. Bharat Biotech Recent Development Table 76. Inovio Pharmaceuticals and GeneOne Life Sciences Company Information Table 77. Inovio Pharmaceuticals and GeneOne Life Sciences Business Overview Table 78. Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Product Portfolio Table 80. Inovio Pharmaceuticals and GeneOne Life Sciences Recent Development Table 81. Intrexon Company Information Table 82. Intrexon Business Overview Table 83. Intrexon Zika Virus Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Intrexon Zika Virus Product Portfolio Table 85. Intrexon Recent Development Table 86. Cerus Company Information Table 87. Cerus Business Overview Table 88. Cerus Zika Virus Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Cerus Zika Virus Product Portfolio Table 90. Cerus Recent Development Table 91. Sanofi Company Information Table 92. Sanofi Business Overview Table 93. Sanofi Zika Virus Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Sanofi Zika Virus Product Portfolio Table 95. Sanofi Recent Development Table 96. NewLink Genetics Company Information Table 97. NewLink Genetics Business Overview Table 98. NewLink Genetics Zika Virus Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. NewLink Genetics Zika Virus Product Portfolio Table 100. NewLink Genetics Recent Development Table 101. Immunovaccine Company Information Table 102. Immunovaccine Business Overview Table 103. Immunovaccine Zika Virus Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Immunovaccine Zika Virus Product Portfolio Table 105. Immunovaccine Recent Development Table 106. GlaxoSmithKline Company Information Table 107. GlaxoSmithKline Business Overview Table 108. GlaxoSmithKline Zika Virus Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. GlaxoSmithKline Zika Virus Product Portfolio Table 110. GlaxoSmithKline Recent Development Table 111. North America Zika Virus Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America Zika Virus Sales by Country (2021-2026) & (K Units) Table 113. North America Zika Virus Sales Market Share by Country (2021-2026) Table 114. North America Zika Virus Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America Zika Virus Sales Market Share Forecast by Country (2027-2032) Table 116. North America Zika Virus Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Zika Virus Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Zika Virus Market Share by Country (2021-2026) Table 119. North America Zika Virus Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Zika Virus Market Share Forecast by Country (2027-2032) Table 121. Europe Zika Virus Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe Zika Virus Sales by Country (2021-2026) & (K Units) Table 123. Europe Zika Virus Sales Market Share by Country (2021-2026) Table 124. Europe Zika Virus Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe Zika Virus Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Zika Virus Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Zika Virus Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Zika Virus Market Share by Country (2021-2026) Table 129. Europe Zika Virus Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Zika Virus Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Zika Virus Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Zika Virus Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific Zika Virus Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Zika Virus Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific Zika Virus Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Zika Virus Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Zika Virus Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Zika Virus Market Share by Country (2021-2026) Table 139. Asia-Pacific Zika Virus Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Zika Virus Market Share Forecast by Country (2027-2032) Table 141. Latin America Zika Virus Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America Zika Virus Sales by Country (2021-2026) & (K Units) Table 143. Latin America Zika Virus Sales Market Share by Country (2021-2026) Table 144. Latin America Zika Virus Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America Zika Virus Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Zika Virus Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Zika Virus Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Zika Virus Market Share by Country (2021-2026) Table 149. Latin America Zika Virus Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Zika Virus Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Zika Virus Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Zika Virus Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa Zika Virus Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Zika Virus Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Zika Virus Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Zika Virus Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Zika Virus Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Zika Virus Market Share by Country (2021-2026) Table 159. Middle East and Africa Zika Virus Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Zika Virus Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Zika Virus Distributors List Table 164. Zika Virus Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Zika Virus Image Figure 2. Global Zika Virus Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zika Virus Market Size (2021-2032) & (US$ Million) Figure 4. Global Zika Virus Sales (2021-2032) & (K Units) Figure 5. Molecular Test Image Figure 6. Global Molecular Test Sales YoY Growth (2021-2032) & (K Units) Figure 7. Serologic Test Image Figure 8. Global Serologic Test Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Zika Virus Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Zika Virus Market Share by Type 2025 VS 2032 Figure 11. North America Zika Virus Sales Market Share in Volume by Type in 2025 Figure 12. North America Zika Virus Sales Market Share in Value by Type in 2025 Figure 13. Europe Zika Virus Sales Market Share in Volume by Type in 2025 Figure 14. Europe Zika Virus Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Zika Virus Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Zika Virus Sales Market Share in Value by Type in 2025 Figure 17. Latin America Zika Virus Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Zika Virus Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Zika Virus Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Zika Virus Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Zika Virus Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Diagnostic Centers Image Figure 24. Global Diagnostic Centers Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Pathology Labs Image Figure 28. Global Pathology Labs Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Zika Virus Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Zika Virus Market Share by Application 2025 VS 2032 Figure 31. North America Zika Virus Sales Market Share in Volume by Application in 2025 Figure 32. North America Zika Virus Sales Market Share in Value by Application in 2025 Figure 33. Europe Zika Virus Sales Market Share in Volume by Application in 2025 Figure 34. Europe Zika Virus Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Zika Virus Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Zika Virus Sales Market Share in Value by Application in 2025 Figure 37. Latin America Zika Virus Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Zika Virus Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Zika Virus Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Zika Virus Sales Market Share in Value by Application in 2025 Figure 41. North America Zika Virus Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Zika Virus Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Zika Virus Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Zika Virus Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Zika Virus Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Zika Virus Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Zika Virus Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Zika Virus Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Zika Virus Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Zika Virus Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Zika Virus Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Zika Virus Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Zika Virus Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Zika Virus Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Zika Virus Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Zika Virus Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Zika Virus Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Zika Virus Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Zika Virus Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Zika Virus Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Zika Virus Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Zika Virus Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Molecular Test
  • Serologic Test
Applications
  • Diagnostic Centers
  • Hospitals
  • Pathology Labs
Companies covered
  • Bharat Biotech
  • Inovio Pharmaceuticals and GeneOne Life Sciences
  • Intrexon
  • Cerus
  • Sanofi
  • NewLink Genetics
  • Immunovaccine
  • GlaxoSmithKline

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Zika Virus Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Zika Virus Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Zika Virus Market by Type
  6. 1.3.1 Molecular Test
  7. 1.3.2 Serologic Test
  8. 1.4 Global Zika Virus Market Size by Type
  9. 1.4.1 Global Zika Virus Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Zika Virus Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Zika Virus Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Zika Virus Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Zika Virus Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Zika Virus Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Zika Virus Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Zika Virus Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Zika Virus Industry Trends
  2. 2.2 Zika Virus Industry Drivers
  3. 2.3 Zika Virus Industry Opportunities and Challenges
  4. 2.4 Zika Virus Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Zika Virus Revenue (2021-2026)
  2. 3.2 Global Top Players by Zika Virus Sales (2021-2026)
  3. 3.3 Global Top Players by Zika Virus Price (2021-2026)
  4. 3.4 Global Zika Virus Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Zika Virus Major Company Production Sites & Headquarters
  6. 3.6 Global Zika Virus Company, Product Type & Application
  7. 3.7 Global Zika Virus Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Zika Virus Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Zika Virus Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Zika Virus Tier 1, Tier 2, and Tier 3
4 Zika Virus Regional Status and Outlook
  1. 4.1 Global Zika Virus Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Zika Virus Historic Market Size by Region
  3. 4.2.1 Global Zika Virus Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Zika Virus Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Zika Virus Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Zika Virus Forecasted Market Size by Region
  7. 4.3.1 Global Zika Virus Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Zika Virus Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Zika Virus Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Zika Virus by Application
  1. 5.1 Zika Virus Market by Application
  2. 5.1.1 Diagnostic Centers
  3. 5.1.2 Hospitals
  4. 5.1.3 Pathology Labs
  5. 5.2 Global Zika Virus Market Size by Application
  6. 5.2.1 Global Zika Virus Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Zika Virus Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Zika Virus Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Zika Virus Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Zika Virus Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Zika Virus Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Zika Virus Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Zika Virus Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bharat Biotech
  2. 6.1.1 Bharat Biotech Company Information
  3. 6.1.2 Bharat Biotech Business Overview
  4. 6.1.3 Bharat Biotech Zika Virus Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bharat Biotech Zika Virus Product Portfolio
  6. 6.1.5 Bharat Biotech Recent Developments
  7. 6.2 Inovio Pharmaceuticals and GeneOne Life Sciences
  8. 6.2.1 Inovio Pharmaceuticals and GeneOne Life Sciences Company Information
  9. 6.2.2 Inovio Pharmaceuticals and GeneOne Life Sciences Business Overview
  10. 6.2.3 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Inovio Pharmaceuticals and GeneOne Life Sciences Zika Virus Product Portfolio
  12. 6.2.5 Inovio Pharmaceuticals and GeneOne Life Sciences Recent Developments
  13. 6.3 Intrexon
  14. 6.3.1 Intrexon Company Information
  15. 6.3.2 Intrexon Business Overview
  16. 6.3.3 Intrexon Zika Virus Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Intrexon Zika Virus Product Portfolio
  18. 6.3.5 Intrexon Recent Developments
  19. 6.4 Cerus
  20. 6.4.1 Cerus Company Information
  21. 6.4.2 Cerus Business Overview
  22. 6.4.3 Cerus Zika Virus Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Cerus Zika Virus Product Portfolio
  24. 6.4.5 Cerus Recent Developments
  25. 6.5 Sanofi
  26. 6.5.1 Sanofi Company Information
  27. 6.5.2 Sanofi Business Overview
  28. 6.5.3 Sanofi Zika Virus Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi Zika Virus Product Portfolio
  30. 6.5.5 Sanofi Recent Developments
  31. 6.6 NewLink Genetics
  32. 6.6.1 NewLink Genetics Company Information
  33. 6.6.2 NewLink Genetics Business Overview
  34. 6.6.3 NewLink Genetics Zika Virus Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 NewLink Genetics Zika Virus Product Portfolio
  36. 6.6.5 NewLink Genetics Recent Developments
  37. 6.7 Immunovaccine
  38. 6.7.1 Immunovaccine Company Information
  39. 6.7.2 Immunovaccine Business Overview
  40. 6.7.3 Immunovaccine Zika Virus Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Immunovaccine Zika Virus Product Portfolio
  42. 6.7.5 Immunovaccine Recent Developments
  43. 6.8 GlaxoSmithKline
  44. 6.8.1 GlaxoSmithKline Company Information
  45. 6.8.2 GlaxoSmithKline Business Overview
  46. 6.8.3 GlaxoSmithKline Zika Virus Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GlaxoSmithKline Zika Virus Product Portfolio
  48. 6.8.5 GlaxoSmithKline Recent Developments
7 North America by Country
  1. 7.1 North America Zika Virus Sales by Country
  2. 7.1.1 North America Zika Virus Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Zika Virus Sales by Country (2021-2026)
  4. 7.1.3 North America Zika Virus Sales Forecast by Country (2027-2032)
  5. 7.2 North America Zika Virus Market Size by Country
  6. 7.2.1 North America Zika Virus Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Zika Virus Market Size by Country (2021-2026)
  8. 7.2.3 North America Zika Virus Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Zika Virus Sales by Country
  2. 8.1.1 Europe Zika Virus Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Zika Virus Sales by Country (2021-2026)
  4. 8.1.3 Europe Zika Virus Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Zika Virus Market Size by Country
  6. 8.2.1 Europe Zika Virus Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Zika Virus Market Size by Country (2021-2026)
  8. 8.2.3 Europe Zika Virus Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Zika Virus Sales by Country
  2. 9.1.1 Asia-Pacific Zika Virus Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Zika Virus Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Zika Virus Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Zika Virus Market Size by Country
  6. 9.2.1 Asia-Pacific Zika Virus Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Zika Virus Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Zika Virus Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Zika Virus Sales by Country
  2. 10.1.1 South America Zika Virus Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Zika Virus Sales by Country (2021-2026)
  4. 10.1.3 South America Zika Virus Sales Forecast by Country (2027-2032)
  5. 10.2 South America Zika Virus Market Size by Country
  6. 10.2.1 South America Zika Virus Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Zika Virus Market Size by Country (2021-2026)
  8. 10.2.3 South America Zika Virus Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Zika Virus Sales by Country
  2. 11.1.1 Middle East and Africa Zika Virus Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Zika Virus Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Zika Virus Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Zika Virus Market Size by Country
  6. 11.2.1 Middle East and Africa Zika Virus Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Zika Virus Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Zika Virus Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Zika Virus Value Chain Analysis
  2. 12.1.1 Zika Virus Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Zika Virus Production Mode & Process
  7. 12.2 Zika Virus Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Zika Virus Distributors
  10. 12.2.3 Zika Virus Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst